Blair William & CO Takeda Pharmaceutical CO LTD Transaction History

Blair William & CO

$33.5 Billion
Q4 2024

A detailed history of Blair William & CO transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Blair William & CO holds 12,199 shares of TAK stock, worth $175,177. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,199

Previous 11,286 8.09%

Holding current value

$175,177

Previous $160,000 0.63%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$13.01 - $14.43 $11,878 - $13,174	913 Added 8.09%	12,199 $161,000
Q3 2024 Nov 12, 2024	SELL	$13.0 - $15.08 $10,920 - $12,667	-840 Reduced 6.93%	11,286 $160,000
Q2 2024 Aug 12, 2024	SELL	$12.6 - $13.67 $6,589 - $7,149	-523 Reduced 4.13%	12,126 $156,000
Q1 2024 May 09, 2024	BUY	$13.89 - $15.04 $10,792 - $11,686	777 Added 6.54%	12,649 $175,000
Q4 2023 Feb 12, 2024	BUY	$13.36 - $15.43 $2,712 - $3,132	203 Added 1.74%	11,872 $169,000
Q2 2023 Aug 11, 2023	SELL	$15.57 - $17.11 $856 - $941	-55 Reduced 0.47%	11,669 $183,000
Q1 2023 May 12, 2023	SELL	$15.28 - $16.48 $840 - $906	-55 Reduced 0.47%	11,724 $193,000
Q4 2022 Feb 10, 2023	BUY	$12.42 - $15.62 $37 - $46	3 Added 0.03%	11,779 $183,000
Q3 2022 Nov 09, 2022	BUY	$12.8 - $28.65 $10,009 - $22,404	782 Added 7.11%	11,776 $153,000
Q2 2022 Aug 10, 2022	SELL	$13.12 - $15.03 $13,526 - $15,495	-1,031 Reduced 8.57%	10,994 $154,000
Q1 2022 May 13, 2022	BUY	$13.54 - $15.35 $5,280 - $5,986	390 Added 3.35%	12,025 $172,000
Q4 2021 Feb 14, 2022	SELL	$13.17 - $16.4 $16,949 - $21,106	-1,287 Reduced 9.96%	11,635 $159,000
Q3 2021 Nov 12, 2021	BUY	$16.3 - $17.26 $1,564 - $1,656	96 Added 0.75%	12,922 $212,000
Q2 2021 Aug 12, 2021	SELL	$16.55 - $18.64 $7,000 - $7,884	-423 Reduced 3.19%	12,826 $216,000
Q1 2021 May 13, 2021	BUY	$16.71 - $19.9 $5,614 - $6,686	336 Added 2.6%	13,249 $242,000
Q4 2020 Feb 09, 2021	SELL	$15.39 - $18.97 $22,238 - $27,411	-1,445 Reduced 10.06%	12,913 $235,000
Q3 2020 Nov 06, 2020	SELL	$17.1 - $19.19 $9,131 - $10,247	-534 Reduced 3.59%	14,358 $256,000
Q2 2020 Aug 12, 2020	BUY	$14.59 - $19.5 $12,839 - $17,160	880 Added 6.28%	14,892 $267,000
Q1 2020 May 11, 2020	BUY	$13.02 - $20.31 $6,822 - $10,642	524 Added 3.88%	14,012 $213,000
Q4 2019 Feb 13, 2020	SELL	$16.88 - $20.83 $60,025 - $74,071	-3,556 Reduced 20.86%	13,488 $266,000
Q3 2019 Nov 12, 2019	BUY	$16.15 - $17.99 $26,808 - $29,863	1,660 Added 10.79%	17,044 $293,000
Q2 2019 Aug 13, 2019	SELL	$16.58 - $20.49 $13,363 - $16,514	-806 Reduced 4.98%	15,384 $272,000
Q1 2019 May 14, 2019	BUY	$16.7 - $21.52 $270,373 - $348,408	16,190 New	16,190 $330,000

Others Institutions Holding TAK

# of Institutions

338

Shares Held

68.6M

Call Options Held

1.72M

Put Options Held

178K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $44.6B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account